ACE Angiotensin-Converting Enzyme
ADR Adverse Drug Reaction
ATS American Thoracic Society
ATT Anti-Tuberculosis Therapy
CAD Coronary Artery Disease
CKD Chronic Kidney Disease
CLD Chronic Obstructive Pulmonary Disease
CSR Corporate Social Responsibility
DM Diabetes Mellitus
DNA Deoxy Ribonucleic Acid
DTO District Tuberculosis Officer
DRTB Drug Resistant Tuberculosis
DSTB Drug-Sensitive Tuberculosis
ERS European Respiratory Society
HIV Human Immunodeficiency Virus
ICP Individualized Care Plan
ICU Intensive Care Unit
INH Isoniazid
IP In Patient
IV Intravenous
SC Subcutaneous
MDR TB Multi Drug Resistant Tuberculosis
RRTB Rifampicin Resistant Tuberculosis
MO-DTC Medical Officer District Tuberculosis Centre
Mos Medical Officer
NGO Non-Governmental Organization
NSAIDS Non-Steroidal Anti-Inflammatory Drugs
NTEP National Tuberculosis Elimination Program
PMDT Programmatic Management of Drug-Resistant Tuberculosis
PMTMBA Pradhan Mantri TB Mukt Bharat Abhiyaan
PTB Pulmonary Tuberculosis
PTLD Post-Tuberculosis Lung Diseases
RNA Ribonucleic Acid
SAM Severe Acute Malnutrition
TB Tuberculosis
TBHV Tuberculosis Health Visitor
TDS- Ter Die Sumendum (3 Times a Day)
BD Twice Daily (Bi-Side)
OD Once a Day
WHO World Health Organization
XDR TB Extensive Drug Resistant Tuberculosis
- Printer-friendly version
- Log in to post comments